233 related articles for article (PubMed ID: 29611034)
1. Finding cancer driver mutations in the era of big data research.
Poulos RC; Wong JWH
Biophys Rev; 2019 Feb; 11(1):21-29. PubMed ID: 29611034
[TBL] [Abstract][Full Text] [Related]
2. Identification of coding and non-coding mutational hotspots in cancer genomes.
Piraino SW; Furney SJ
BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
[TBL] [Abstract][Full Text] [Related]
3. Beyond the exome: the role of non-coding somatic mutations in cancer.
Piraino SW; Furney SJ
Ann Oncol; 2016 Feb; 27(2):240-8. PubMed ID: 26598542
[TBL] [Abstract][Full Text] [Related]
4. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.
Cheng F; Zhao J; Zhao Z
Brief Bioinform; 2016 Jul; 17(4):642-56. PubMed ID: 26307061
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
Nono AD; Chen K; Liu X
BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
[TBL] [Abstract][Full Text] [Related]
6. Annotation of Variant Data from High-Throughput DNA Sequencing from Tumor Specimens: Filtering Strategies to Identify Driver Mutations.
Sun S; Thorson JA; Murray SS
Methods Mol Biol; 2019; 1908():49-60. PubMed ID: 30649720
[TBL] [Abstract][Full Text] [Related]
7. Looking beyond drivers and passengers in cancer genome sequencing data.
De S; Ganesan S
Ann Oncol; 2017 May; 28(5):938-945. PubMed ID: 27998972
[TBL] [Abstract][Full Text] [Related]
8. Mining the coding and non-coding genome for cancer drivers.
Li J; Drubay D; Michiels S; Gautheret D
Cancer Lett; 2015 Dec; 369(2):307-15. PubMed ID: 26433158
[TBL] [Abstract][Full Text] [Related]
9. CScape-somatic: distinguishing driver and passenger point mutations in the cancer genome.
Rogers MF; Gaunt TR; Campbell C
Bioinformatics; 2020 Jun; 36(12):3637-3644. PubMed ID: 32282885
[TBL] [Abstract][Full Text] [Related]
10. Translating cancer genomes sequencing revolution into surgical oncology practice.
Katsios C; Ziogas DE; Liakakos T; Zoras O; Roukos DH
J Surg Res; 2012 Apr; 173(2):365-9. PubMed ID: 21195428
[TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer Analysis Reveals the Functional Importance of Protein Lysine Modification in Cancer Development.
Chen L; Miao Y; Liu M; Zeng Y; Gao Z; Peng D; Hu B; Li X; Zheng Y; Xue Y; Zuo Z; Xie Y; Ren J
Front Genet; 2018; 9():254. PubMed ID: 30065750
[TBL] [Abstract][Full Text] [Related]
12. Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate.
Juul M; Bertl J; Guo Q; Nielsen MM; Świtnicki M; Hornshøj H; Madsen T; Hobolth A; Pedersen JS
Elife; 2017 Mar; 6():. PubMed ID: 28362259
[TBL] [Abstract][Full Text] [Related]
13. Evaluating somatic tumor mutation detection without matched normal samples.
Teer JK; Zhang Y; Chen L; Welsh EA; Cress WD; Eschrich SA; Berglund AE
Hum Genomics; 2017 Sep; 11(1):22. PubMed ID: 28870239
[TBL] [Abstract][Full Text] [Related]
14. Using common variants to indicate cancer genes.
Stead LF; Thygesen H; Westhead DR; Rabbitts P
Int J Cancer; 2015 Jan; 136(1):241-5. PubMed ID: 24798945
[TBL] [Abstract][Full Text] [Related]
15. Mutational Signatures Are Critical for Proper Estimation of Purifying Selection Pressures in Cancer Somatic Mutation Data When Using the dN/dS Metric.
Van den Eynden J; Larsson E
Front Genet; 2017; 8():74. PubMed ID: 28642787
[TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of somatic mutations driving cancer: uncovering functional protein regions in disease development.
Mészáros B; Zeke A; Reményi A; Simon I; Dosztányi Z
Biol Direct; 2016 May; 11():23. PubMed ID: 27150584
[TBL] [Abstract][Full Text] [Related]
17. Non-coding driver mutations in human cancer.
Elliott K; Larsson E
Nat Rev Cancer; 2021 Aug; 21(8):500-509. PubMed ID: 34230647
[TBL] [Abstract][Full Text] [Related]
18. Commonalities and differences in the mutational signature and somatic driver mutation landscape across solid and hollow viscus organs.
Ng AS; Chan DKH
Oncogene; 2023 Sep; 42(37):2713-2724. PubMed ID: 37573406
[TBL] [Abstract][Full Text] [Related]
19. Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era.
Porta-Pardo E; Valencia A; Godzik A
FEBS Lett; 2020 Dec; 594(24):4233-4246. PubMed ID: 32239503
[TBL] [Abstract][Full Text] [Related]
20. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
Zhang W; Wang SL
Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
